Fig. 1
From: 18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
48-year-old female patient with a history of surgically treated colon cancer. Follow-up 18F-FDG PET/CT scanning (images A–F) revealed metabolic and morphologic regression of the previously noted nodular lesion in the recto-uterine pouch encroaching on the thickened rectal wall, with a SUVmax of 10.5 compared to 16.7. Other FDG-avid lesions (images G–O) beneath and within the anterior abdominal wall (currently measuring about 1.0 cm vs. 1.7 cm, with aSUVmax of 2.8 vs. 11.2)